Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
18010 | 509 | 31.1 | 74% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1388 | 7661 | CONGENITAL HEART BLOCK//NEONATAL LUPUS//NEONATAL LUPUS ERYTHEMATOSUS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ANTINUCLEAR ANTIBODIES | Author keyword | 19 | 19% | 18% | 90 |
2 | INDIRECT IMMUNOFLUORESCENCE | Author keyword | 6 | 14% | 8% | 43 |
3 | ANA | Author keyword | 4 | 17% | 5% | 23 |
4 | HEP 2 CELL CLASSIFICATION | Author keyword | 4 | 50% | 1% | 6 |
5 | LUCIFERASE IMMUNOPRECIPITATION SYSTEMS | Author keyword | 4 | 75% | 1% | 3 |
6 | NEUROBIOL PAIN THER EUT SECT | Address | 4 | 23% | 3% | 14 |
7 | AUTOIMMUNOLOGY | Author keyword | 3 | 50% | 1% | 5 |
8 | SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES | Author keyword | 3 | 50% | 1% | 5 |
9 | ANTI EXTRACTABLE NUCLEAR ANTIGENS | Author keyword | 3 | 100% | 1% | 3 |
10 | LINE IMMUNOASSAY | Author keyword | 3 | 35% | 1% | 7 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANA | 29 | 48% | 9% | 44 |
2 | ANTINUCLEAR ANTIBODIES | 10 | 10% | 18% | 92 |
3 | DEFINED SPECIFICITIES | 8 | 56% | 2% | 10 |
4 | HEP 2 CELL EXTRACT | 8 | 100% | 1% | 5 |
5 | EXTRACTABLE NUCLEAR ANTIGENS | 7 | 34% | 3% | 17 |
6 | AUTOANTIBODY DETECTION | 7 | 57% | 2% | 8 |
7 | IMMUNOFLUORESCENCE PATTERNS | 7 | 57% | 2% | 8 |
8 | 4 ANTIGEN MIXTURE | 6 | 71% | 1% | 5 |
9 | NUCLEAR ANTIGENS | 6 | 17% | 6% | 32 |
10 | AUTOANTIBODY TESTS | 4 | 67% | 1% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies | 2014 | 38 | 43 | 58% |
Automated antinuclear immunofluorescence antibody screening: A comparative study of six computer-aided diagnostic systems | 2014 | 11 | 23 | 87% |
Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis | 2012 | 22 | 16 | 69% |
A comparative study on the reliability of an automated system for the evaluation of cell-based indirect immunofluorescence | 2012 | 24 | 22 | 64% |
Current state of diagnostic technologies in the autoimmunology laboratory | 2013 | 8 | 77 | 70% |
Luciferase immunoprecipitation systems for measuring antibodies in autoimmune and infectious diseases | 2015 | 1 | 59 | 32% |
Novel opportunities in automated classification of antinuclear antibodies on HEp-2 cells | 2011 | 14 | 22 | 82% |
New Platform Technology for Comprehensive Serological Diagnostics of Autoimmune Diseases | 2012 | 8 | 43 | 67% |
Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited | 2009 | 25 | 32 | 50% |
Autoantibody diagnostics in clinical practice | 2012 | 12 | 24 | 50% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEUROBIOL PAIN THER EUT SECT | 4 | 23% | 2.8% | 14 |
2 | AUTOINMUNIDAD | 2 | 33% | 0.8% | 4 |
3 | IST AUXIOL | 1 | 100% | 0.4% | 2 |
4 | COMP SCI BIOINFORMAT | 1 | 33% | 0.6% | 3 |
5 | DENT CLIN CORE | 1 | 40% | 0.4% | 2 |
6 | LUDWIG BOLTZMANN RHEUMATOL | 1 | 40% | 0.4% | 2 |
7 | IMMUNOL ALLERGOL UNIT | 1 | 22% | 0.8% | 4 |
8 | CLIN MED IMMUNOL RHEUMATOL | 1 | 33% | 0.4% | 2 |
9 | AD HOC COMM IMMUNOL TESTING GUIDELINES | 1 | 50% | 0.2% | 1 |
10 | ANTINUCL ANTIBODY | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000277854 | MIXED CONNECTIVE TISSUE DISEASE//LA SS B//RO SS A |
2 | 0.0000188146 | HEPATOMA DERIVED GROWTH FACTOR//HDGF//HEPATOMA DERIVED GROWTH FACTOR HDGF |
3 | 0.0000123873 | ANTI DNA//ANTI DNA ANTIBODIES//ANTI DSDNA ANTIBODIES |
4 | 0.0000098127 | SYSTEMIC SCLEROSIS//SCLERODERMA//SCLERODERMA RENAL CRISIS |
5 | 0.0000075857 | CITRULLINATION//PEPTIDYLARGININE DEIMINASE//ANTIPERINUCLEAR FACTOR |
6 | 0.0000060648 | DANISH REGISTER MULTIPLE SCLEROSIS//LUPOID SCLEROSIS//AUTOIMMUNE TAUTOLOGY |
7 | 0.0000057668 | LUPUS NEPHRITIS//SYSTEMIC LUPUS ERYTHEMATOSUS//LUPUS |
8 | 0.0000054421 | P53 AUTOANTIBODIES//ANTI P53 ANTIBODY//SERUM P53 ANTIBODY |
9 | 0.0000047365 | CIBER BBN SALUD CARLOS 3//RIER RED INFLAMAC ENFERMEDADES REUMAT//PROTEORED ISCIII PROTE GRP |
10 | 0.0000045969 | WESTERGREN METHOD//ERYTHROCYTE SEDIMENTATION RATE//WESTERGREN |